tradingkey.logo
tradingkey.logo
検索

Sanofi SA

SNY
ウォッチリストに追加
44.260USD
-0.070-0.16%
終値 09-04 16:00ET
105.99B時価総額
12.30直近12ヶ月PER

詳細情報 Sanofi SA 企業名

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Sanofi SA プロフィール

企業コードSNY
会社名Sanofi SA
上場日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)
従業員数84587
証券種類Depository Receipt
決算期末Jul 01
本社所在地46 Avenue de la Grande Armee
都市PARIS
証券取引所NASDAQ OMX - NASDAQ BASIC
France
郵便番号75017
電話番号33153774000
ウェブサイトhttps://www.sanofi.com/
企業コードSNY
上場日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)

Sanofi SAの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Ms. Rachel Duan
Ms. Rachel Duan
Independent Director
Independent Director
--
--
Ms. Lise Kingo
Ms. Lise Kingo
Independent Director
Independent Director
--
--
Ms. Natalie Bickford
Ms. Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Chief People Officer, Executive Vice President, Member of the Executive Committee
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--

よくある質問

Sanofi SAの上位5名の株主は誰ですか?

Sanofi SAの上位5名の株主は以下のとおりです。Mr. Olivier Charmeil

Sanofi SA(SNY)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Sanofi SAの株式を保有している機関は1330社あり、保有株式の総市場価値は約225.52Mで、全体の9.34%を占めています。2025Q4と比較して、機関の持ち株は-36323619.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。